Boston Scientific's $3.7B Axonics Buy Under FTC Microscope
By Jade Martinez-Pogue · April 4, 2024, 3:50 PM EDT
Biomedical engineering company Boston Scientific Corp. on Thursday disclosed that the Federal Trade Commission requested more information on its planned $3.7 billion acquisition of medical technology company Axonics, which will result...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login